{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:41:19Z","timestamp":1776235279973,"version":"3.50.1"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Cholestatic liver injury (CLI) is a complex pathology characterized by impaired bile excretion and a lack of effective curative therapies. Emerging evidence indicates that the gut microbiota plays a critical role in the pathogenesis of CLI via the gut-liver axis. Specifically, gut dysbiosis disrupts bile acid homeostasis, triggers immune-mediated inflammation, exacerbates oxidative stress, and dysregulates multiple signaling pathways, thereby accelerating hepatic damage. Traditional Chinese Medicine (TCM) offers a distinct therapeutic advantage through its multi-component, multi-target mechanisms. Many studies have shown that TCM herbal extracts and some formulas can attenuate CLI by restructuring the gut microbiome. These interventions work by promoting beneficial bacterial proliferation, restoring intestinal barrier integrity, modulating bile acid receptors, and suppressing inflammation and fibrosis. This review synthesizes current mechanisms linking gut dysbiosis to CLI and evaluates recent advances in TCM-based strategies that target the gut microbiota, offering theoretical insights for novel clinical interventions.<\/jats:p>","DOI":"10.3389\/fcimb.2026.1807162","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:41:19Z","timestamp":1776231679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic modulation of the gut microbiota by traditional Chinese medicine in the management of cholestatic liver injury"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiyan","family":"Ding","sequence":"first","affiliation":[{"name":"School of Medicine, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicui","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaming","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Medicine, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxin","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: From basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4254\/wjh.v14.i1.98","article-title":"Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies","volume":"14","author":"Alam","year":"2022","journal-title":"World J. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"B4","article-title":"Inhibited TLR-4\/NF-\u03baB pathway mediated by cannabinoid receptor 2 activation curbs ongoing liver fibrosis in bile duct ligated rats","volume-title":"Adv. Anim. Vet.","author":"Ali","year":"2021"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711217","article-title":"Gut-liver immune traffic: Deciphering immune-pathogenesis to underpin translational therapy","volume":"12","author":"Bozward","year":"2021","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2359677","article-title":"The human gut microbiome and aging","volume":"16","author":"Bradley","year":"2024","journal-title":"Gut Microbes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118009","article-title":"Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice","volume":"327","author":"Cai","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16744","article-title":"Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling","volume":"12","author":"Cao","year":"2024","journal-title":"PeerJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13020-025-01161-7","article-title":"Pien-Tze-Huang alleviates lithocholic acid-induced cholestasis in mice by shaping bile acid-submetabolome","volume":"20","author":"Cao","year":"2025","journal-title":"Chin. Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2394249","article-title":"Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation","volume":"16","author":"Casado-Bedmar","year":"2024","journal-title":"Gut Microbes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70429","article-title":"Disruption of bile acid metabolism in the gut-liver axis predisposes mice to inflammatory bowel disease","volume":"6","author":"Chang","year":"2025","journal-title":"MedComm (2020)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156164","article-title":"Chidan Tuihuang granule modulates gut microbiota to influence NOD1\/RIPK2 pathway in cholestatic liver injury recovery","volume":"135","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41430-020-0607-6","article-title":"Profile of the gut microbiota of adults with obesity: a systematic review","volume":"74","author":"Crovesy","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5009\/gnl240539","article-title":"Gut-liver axis: The role of intestinal microbiota and their metabolites in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"19","author":"Cui","year":"2025","journal-title":"Gut Liver"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118910","article-title":"Bie Jia Jian pill ameliorates BDL-induced cholestatic hepatic fibrosis in rats by regulating intestinal microbial composition and TMAO-mediated PI3K\/AKT signaling pathway","volume":"337","author":"Cui","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10060911","article-title":"Effects of C60 fullerene on thioacetamide-induced rat liver toxicity and gut microbiome changes","volume":"10","author":"\u0110ura\u0161evi\u0107","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3760\/cma.j.cn.441530-20201009-00550","article-title":"Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal failure-associated liver disease","volume":"24","author":"Fan","year":"2021","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijbiomac.2022.02.056","article-title":"Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4\/NF-\u03baB signaling pathway","volume":"205","author":"Fang","year":"2022","journal-title":"Int. J. Biol. Macromol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1021\/cbe.5c00021","article-title":"Mechanisms and strategies for engineering oxidative stress resistance in Saccharomyces cerevisiae","volume":"2","author":"Feng","year":"2025","journal-title":"Chem. Bio Eng"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/app151810191","article-title":"Oxidative stress fundamentals: Unraveling the pathophysiological role of redox imbalance in non-communicable diseases","volume":"15","author":"Garcia-Llorens","year":"2025","journal-title":"Appl. Sci."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031397","article-title":"Bile acids and microbiota: Multifaceted and versatile regulators of the liver-gut axis","volume":"22","author":"Gr\u00fcner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084321","article-title":"Exploring advanced therapies for primary biliary cholangitis: Insights from the gut microbiota-bile acid-immunity network","volume":"25","author":"Guo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091949","article-title":"IL-13 as target to reduce cholestasis and dysbiosis in Abcb4 knockout mice","volume":"9","author":"Hahn","year":"2020","journal-title":"Cells"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.001608","article-title":"The interaction between IL-17 and gut microbiota contributes to cholestatic liver disease in children","volume":"171","author":"He","year":"2025","journal-title":"Microbiol. (Reading)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"G582","DOI":"10.1152\/ajpgi.00344.2019","article-title":"Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH","volume":"318","author":"Hernandez","year":"2020","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105444","article-title":"Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects","volume":"165","author":"Hu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jlb.3ma0321-037r","article-title":"Gut microbiota contributes to sexual dimorphism in murine autoimmune cholangitis","volume":"110","author":"Huang","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.984697","article-title":"Disease predisposition of human leukocyte antigen class II genes influences the gut microbiota composition in patients with primary biliary cholangitis","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/hep.31228","article-title":"Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00964-24","article-title":"Dietary fiber monosaccharide content alters gut microbiome composition and fermentation","volume":"90","author":"Jensen","year":"2024","journal-title":"Appl. Environ. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2383353","article-title":"The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC","volume":"16","author":"Jiang","year":"2024","journal-title":"Gut Microbes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2025.111740","article-title":"Geniposide induces hepatotoxicity via the bile acid-induced activation of NLRP3 inflammasome and regulation of the FXR\/PERK\/TXNIP pathway","volume":"413","author":"Jin","year":"2025","journal-title":"Toxicol. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1911534","article-title":"Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns","volume":"13","author":"Juanola","year":"2021","journal-title":"Gut Microbes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.16114","article-title":"Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health","volume":"12","author":"Kandalgaonkar","year":"2024","journal-title":"Physiol. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/labinvest.2016.112","article-title":"Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice","volume":"96","author":"Kennedy","year":"2016","journal-title":"Lab. Invest"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12112333","article-title":"Unraveling the role of the human gut microbiome in health and diseases","volume":"12","author":"Khalil","year":"2024","journal-title":"Microorganisms"},{"key":"B44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41419-020-2663-1","article-title":"Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death Dis."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41522-023-00398-0","article-title":"Impaired flux of bile acids from the liver to the gut reveals microbiome-immune interactions associated with liver damage","volume":"9","author":"Leung","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s1875-5364(20)30023-6","article-title":"Targeted bile acids and gut microbiome profiles reveal the hepato-protective effect of WZ tablet (Schisandra sphenanthera extract) against LCA-induced cholestasis","volume":"18","author":"Li","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.chom.2024.11.002","article-title":"Zinc promotes microbial p-coumaric acid production that protects against cholestatic liver injury","volume":"32","author":"Li","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118804","article-title":"Si-Ni-San ameliorates cholestatic liver injury by favoring P. goldsteinii colonization","volume":"337","author":"Li","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070932","article-title":"Yinchenhao decoction mitigates cholestatic liver injury in mice via gut microbiota regulation and activation of FXR-FGF15 pathway","volume":"18","author":"Li","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12866-023-02983-x","article-title":"Profiles and integration of the gut microbiome and fecal metabolites in severe intrahepatic cholestasis of pregnancy","volume":"23","author":"Li","year":"2023","journal-title":"BMC Microbiol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.70005","article-title":"Melatonin ameliorates cadmium-induced liver fibrosis via modulating gut microbiota and bile acid metabolism","volume":"76","author":"Liu","year":"2024","journal-title":"J. Pineal Res."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/mi\/4112856","article-title":"NLRP3 inflammasome activation is involved in geniposide-induced hepatotoxicity","volume":"2025","author":"Liu","year":"2025","journal-title":"Mediators Inflamm."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbaf020","article-title":"Bile acid metabolism and hcepatocellular carcinoma: mechanisms of drug resistance and intervention strategies","volume":"8","author":"Lu","year":"2025","journal-title":"Precis Clin. Med."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156495","article-title":"Yinzhihuang formula modulates the microbe\u2013gut\u2013liver axis and bile acid excretion to attenuate cholestatic liver injury","volume":"139","author":"Luo","year":"2025","journal-title":"Phytomedicine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1225742","article-title":"Genetic predisposition of the gastrointestinal microbiome and primary biliary cholangitis: a bi-directional, two-sample Mendelian randomization analysis","volume":"14","author":"Luo","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/s0029665120006916","article-title":"SCFA: mechanisms and functional importance in the gut","volume":"80","author":"Martin-Gallausiaux","year":"2021","journal-title":"Proc. Nutr. Soc"},{"key":"B58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41579-023-00969-0","article-title":"The gut microbiota and its biogeography","volume":"22","author":"McCallum","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/hep.0000000000001341","article-title":"Epidemiological and economical burden of cholestatic liver disease","volume":"82","author":"Mol","year":"2025","journal-title":"Hepatology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab063","article-title":"Deletion of intestinal SHP impairs short-term response to cholic acid challenge in male mice","volume":"162","author":"Nguyen","year":"2021","journal-title":"Endocrinology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061288","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis: current knowledge of pathogenesis and therapeutics","volume":"10","author":"Park","year":"2022","journal-title":"Biomedicines"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i5.99913","article-title":"Unlocking the secrets of the human gut microbiota: comprehensive review on its role in different diseases","volume":"31","author":"Paul","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101168","article-title":"Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis","volume":"6","author":"Roberts","year":"2024","journal-title":"JHEP Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.cmet.2020.03.006","article-title":"Gut-resident lactobacilli activate hepatic Nrf2 and protect against oxidative liver injury","volume":"31","author":"Saeedi","year":"2020","journal-title":"Cell Metab."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1840766","article-title":"Host miRNA-21 promotes liver dysfunction by targeting small intestinal lactobacillus in mice","volume":"12","author":"Santos","year":"2020","journal-title":"Gut Microbes"},{"key":"B67","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/MOG.0b013e32835ff948","article-title":"Linking intestinal homeostasis and liver disease","volume":"29","author":"Schnabl","year":"2013","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35793","article-title":"Combined bacterial translocation and cholestasis aggravates liver injury by activation pyroptosis in obstructive jaundice","volume":"10","author":"Shen","year":"2024","journal-title":"Heliyon"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","article-title":"Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease","volume":"13","author":"Stoeva","year":"2021","journal-title":"Gut Microbes"},{"key":"B70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/s1875-5364(25)60854-5","article-title":"Xiaohuang Qudan decoction alleviates ANIT-induced cholestatic liver injury by inhibiting the JAK2\/STAT3 pathway and regulating TH17\/Treg","volume":"23","author":"Tan","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jointm.2024.06.003","article-title":"Intestine-derived fibroblast growth factor 19 alleviates lipopolysaccharide-induced liver injury by regulating bile acid homeostasis and directly improving oxidative stress","volume":"5","author":"Tang","year":"2025","journal-title":"J. Intensive Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3906\/sag-1404-57","article-title":"Hepatoprotective and antioxidant effects of lycopene in acute cholestasis","volume":"45","author":"Toka\u00e7","year":"2015","journal-title":"Turk J. Med. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"B75","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/hep.28128","article-title":"Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists","volume":"63","author":"Trivedi","year":"2016","journal-title":"Hepatology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3350\/cmh.2025.0577","article-title":"Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-HT production","volume":"32","author":"Tu","year":"2025","journal-title":"Clin. Mol. Hepatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1042\/cs20230812","article-title":"Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition","volume":"137","author":"Verkade","year":"2023","journal-title":"Clin. Sci. (Lond)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.2147\/dddt.S381667","article-title":"Integrated microbiome and metabolome analysis reveals correlations between gut microbiota components and metabolic profiles in mice with methotrexate-induced hepatoxicity","volume":"16","author":"Wang","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13375","article-title":"Gut-liver axis in liver disease: from basic science to clinical treatment (review)","volume":"31","author":"Wang","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41401-024-01417-2","article-title":"Branched-chain amino acids promote hepatic Cyp7a1 expression and bile acid synthesis via suppressing FGF21-ERK pathway","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"B81","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1002\/ptr.8326","article-title":"Gardenia jasminoides Ellis. polysaccharides alleviated cholestatic liver injury by increasing the production of butyric acid and FXR activation","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13578-024-01195-8","article-title":"Therapeutic potential of berberine in attenuating cholestatic liver injury: insights from a PSC mouse model","volume":"14","author":"Wang","year":"2024","journal-title":"Cell Biosci."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1396023","article-title":"Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K\/AKT\/GSK-3\u03b2 signaling pathway and regulating intestinal flora distribution","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03242-22","article-title":"Transcriptome and gut microbiota profiling analysis of ANIT-induced cholestasis and the effects of Da-Huang-Xiao-Shi decoction intervention","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol. Spectr"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/jgh.16544","article-title":"The contribution of small heterodimer partner to the occurrence and progression of cholestatic liver injury","volume":"39","author":"Wei","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4939-9420-5_9","article-title":"Measuring apoptosis and necrosis in cholestatic liver injury","volume":"1981","author":"Woolbright","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/md23070287","article-title":"Rosmarinic acid protects against acetaminophen-induced hepatotoxicity by suppressing ferroptosis and oxidative stress through Nrf2\/HO-1 activation in mice","volume":"23","author":"Wu","year":"2025","journal-title":"Mar. Drugs"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2390176","article-title":"Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion","volume":"16","author":"Wu","year":"2024","journal-title":"Gut Microbes"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03150-24","article-title":"Activation of gut FXR improves the metabolism of bile acids, intestinal barrier, and microbiota under cholestatic condition caused by GCDCA in mice","volume":"13","author":"Xie","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1002922","article-title":"Paeoniae Radix Rubra can enhance fatty acid \u03b2-oxidation and alleviate gut microbiota disorder in \u03b1-naphthyl isothiocyanate induced cholestatic model rats","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41419-023-05615-4","article-title":"Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA\/S1PR2\/ZBP1\/p-MLKL axis","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1039\/d4fo06413e","article-title":"Pterostilbene attenuates intestinal barrier damage and secondary liver oxidative stress in a murine model of Clostridium difficile infection by regulating the gut microbiota","volume":"16","author":"Yang","year":"2025","journal-title":"Food Funct."},{"key":"B93","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5483\/bmbrep.2016.49.10.144","article-title":"The gut microbiota: a key regulator of metabolic diseases","volume":"49","author":"Yang","year":"2016","journal-title":"BMB Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3350\/cmh.2022.0327","article-title":"Taurocholic acid promotes hepatic stellate cell activation via S1PR2\/p38 MAPK\/YAP signaling under cholestatic conditions","volume":"29","author":"Yang","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00127-24","article-title":"Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice","volume":"9","author":"Yang","year":"2024","journal-title":"mSystems"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut Bacteroides species in health and disease","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microbes"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2019.108336","article-title":"Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae\/Lachnospiraceae bacteria in C57BL\/6 mice fed a high-fat diet","volume":"78","author":"Zeng","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118972","article-title":"Desmodium styracifolium (Osb.) Merr. extracts alleviate cholestatic liver disease by FXR pathway","volume":"337","author":"Zhang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/s41467-025-57351-2","article-title":"Chenodeoxycholic acid modulates cholestatic niche through FXR\/Myc\/P-selectin axis in liver endothelial cells","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"B100","doi-asserted-by":"publisher","first-page":"958","DOI":"10.14218\/jcth.2022.00408","article-title":"Targeting gut microbiota for the treatment of primary biliary cholangitis: from bench to bedside","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00416","article-title":"Proteomics unravels emodin causes liver oxidative damage elicited by mitochondrial dysfunction","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/8882667","article-title":"Yinchenhao decoction protects against acute liver injury in mice with biliary acute pancreatitis by regulating the gut microflora-bile acids-liver axis","volume":"2024","author":"Zhao","year":"2024","journal-title":"Gastroenterol. Res. Pract."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.cmet.2024.06.008","article-title":"TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response","volume":"36","author":"Zheng","year":"2024","journal-title":"Cell Metab."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1600439","article-title":"Gut microbiota modulation by traditional Chinese medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1214685","article-title":"The regulatory role of bile acid microbiota in the progression of liver cirrhosis","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113544","article-title":"Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis","volume":"267","author":"Zou","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1547958","article-title":"Gut microbiota dysbiosis in infantile cholestatic hepatopathy","volume":"13","author":"Zou","year":"2025","journal-title":"Front. Pediatr."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1807162\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:41:21Z","timestamp":1776231681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1807162\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":107,"alternative-id":["10.3389\/fcimb.2026.1807162"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1807162","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1807162"}}